APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 1 Diabetes Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Type 1 Diabetes Drugs Industry Growth and Trends Forecast to 2032

Report ID 174043920120 December 2025108 pages

Choose your research edition.

Industry ResearchType 1 Diabetes Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 1 Diabetes Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Type 1 Diabetes Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 1 Diabetes Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 1 Diabetes Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Type 1 Diabetes Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Type 1 Diabetes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Type 1 Diabetes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 1 Diabetes Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 1 Diabetes Drugs include Sanofi, Novo Nordisk, Eli Lily, AstraZeneca, Diamyd Therapeutics AB, Boehringer Ingelheim, Biodel, BHV Pharma and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Type 1 Diabetes Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Type 1 Diabetes Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Type 1 Diabetes Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Type 1 Diabetes Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Type 1 Diabetes Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Type 1 Diabetes Drugs Market by Company

Sanofi

Novo Nordisk

Eli Lily

AstraZeneca

Diamyd Therapeutics AB

Boehringer Ingelheim

Biodel

BHV Pharma

Astellas Pharma

Adocia

Type 1 Diabetes Drugs Segment by Type

Insulins

Others

Type 1 Diabetes Drugs Segment by Application

Drugstore

Hospital

Others

Type 1 Diabetes Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 1 Diabetes Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 1 Diabetes Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 1 Diabetes Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Type 1 Diabetes Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Type 1 Diabetes Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulins Table 2. Major Company of Others Table 3. Global Type 1 Diabetes Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 5. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Type 1 Diabetes Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Type 1 Diabetes Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Type 1 Diabetes Drugs Sales by Type (2027-2032) & (W Units) Table 10. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Type 1 Diabetes Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Type 1 Diabetes Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Type 1 Diabetes Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 15. North America Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 17. Europe Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 21. Latin America Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Type 1 Diabetes Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Type 1 Diabetes Drugs Industry Trends Table 25. Type 1 Diabetes Drugs Industry Drivers Table 26. Type 1 Diabetes Drugs Industry Opportunities and Challenges Table 27. Type 1 Diabetes Drugs Industry Restraints Table 28. Global Type 1 Diabetes Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Type 1 Diabetes Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Type 1 Diabetes Drugs Sales by Company (2021-2026) & (W Units) Table 31. Global Type 1 Diabetes Drugs Sales Share by Company (2021-2026) Table 32. Global Type 1 Diabetes Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Type 1 Diabetes Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Type 1 Diabetes Drugs Major Company Production Sites and Headquarters Table 35. Global Type 1 Diabetes Drugs Company, Product Type & Application Table 36. Global Type 1 Diabetes Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Type 1 Diabetes Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Type 1 Diabetes Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Type 1 Diabetes Drugs Sales by Region (2021-2026) & (W Units) Table 41. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Type 1 Diabetes Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Type 1 Diabetes Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Type 1 Diabetes Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Type 1 Diabetes Drugs Sales by Region (2027-2032) & (W Units) Table 46. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Type 1 Diabetes Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Type 1 Diabetes Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Type 1 Diabetes Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Type 1 Diabetes Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 52. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Type 1 Diabetes Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Type 1 Diabetes Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Type 1 Diabetes Drugs Sales by Application (2027-2032) & (W Units) Table 57. Global Type 1 Diabetes Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Type 1 Diabetes Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Type 1 Diabetes Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Type 1 Diabetes Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 62. North America Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 64. Europe Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 68. Latin America Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Type 1 Diabetes Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Type 1 Diabetes Drugs Product Portfolio Table 75. Sanofi Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk Type 1 Diabetes Drugs Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. Eli Lily Company Information Table 82. Eli Lily Business Overview Table 83. Eli Lily Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lily Type 1 Diabetes Drugs Product Portfolio Table 85. Eli Lily Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Type 1 Diabetes Drugs Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Diamyd Therapeutics AB Company Information Table 92. Diamyd Therapeutics AB Business Overview Table 93. Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Portfolio Table 95. Diamyd Therapeutics AB Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Type 1 Diabetes Drugs Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. Biodel Company Information Table 102. Biodel Business Overview Table 103. Biodel Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Biodel Type 1 Diabetes Drugs Product Portfolio Table 105. Biodel Recent Development Table 106. BHV Pharma Company Information Table 107. BHV Pharma Business Overview Table 108. BHV Pharma Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. BHV Pharma Type 1 Diabetes Drugs Product Portfolio Table 110. BHV Pharma Recent Development Table 111. Astellas Pharma Company Information Table 112. Astellas Pharma Business Overview Table 113. Astellas Pharma Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Astellas Pharma Type 1 Diabetes Drugs Product Portfolio Table 115. Astellas Pharma Recent Development Table 116. Adocia Company Information Table 117. Adocia Business Overview Table 118. Adocia Type 1 Diabetes Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Adocia Type 1 Diabetes Drugs Product Portfolio Table 120. Adocia Recent Development Table 121. North America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Type 1 Diabetes Drugs Sales by Country (2021-2026) & (W Units) Table 123. North America Type 1 Diabetes Drugs Sales Market Share by Country (2021-2026) Table 124. North America Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Type 1 Diabetes Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Type 1 Diabetes Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Type 1 Diabetes Drugs Market Share by Country (2021-2026) Table 129. North America Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Type 1 Diabetes Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Type 1 Diabetes Drugs Sales by Country (2021-2026) & (W Units) Table 133. Europe Type 1 Diabetes Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Type 1 Diabetes Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Type 1 Diabetes Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Type 1 Diabetes Drugs Market Share by Country (2021-2026) Table 139. Europe Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Type 1 Diabetes Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Type 1 Diabetes Drugs Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Type 1 Diabetes Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Type 1 Diabetes Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Type 1 Diabetes Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Type 1 Diabetes Drugs Sales by Country (2021-2026) & (W Units) Table 153. Latin America Type 1 Diabetes Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Type 1 Diabetes Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Type 1 Diabetes Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Type 1 Diabetes Drugs Market Share by Country (2021-2026) Table 159. Latin America Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Type 1 Diabetes Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Type 1 Diabetes Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Type 1 Diabetes Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Type 1 Diabetes Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Type 1 Diabetes Drugs Distributors List Table 174. Type 1 Diabetes Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Type 1 Diabetes Drugs Image Figure 2. Global Type 1 Diabetes Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 1 Diabetes Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 1 Diabetes Drugs Sales (2021-2032) & (W Units) Figure 5. Insulins Image Figure 6. Global Insulins Sales YoY Growth (2021-2032) & (W Units) Figure 7. Others Image Figure 8. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Type 1 Diabetes Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Type 1 Diabetes Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Type 1 Diabetes Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Type 1 Diabetes Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Type 1 Diabetes Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Type 1 Diabetes Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Type 1 Diabetes Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Type 1 Diabetes Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Type 1 Diabetes Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Drugstore Image Figure 24. Global Drugstore Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Type 1 Diabetes Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Type 1 Diabetes Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Type 1 Diabetes Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Type 1 Diabetes Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Type 1 Diabetes Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Type 1 Diabetes Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Type 1 Diabetes Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Type 1 Diabetes Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Type 1 Diabetes Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Type 1 Diabetes Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Type 1 Diabetes Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Type 1 Diabetes Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Type 1 Diabetes Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Type 1 Diabetes Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Type 1 Diabetes Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Type 1 Diabetes Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Type 1 Diabetes Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Type 1 Diabetes Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Type 1 Diabetes Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Type 1 Diabetes Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Type 1 Diabetes Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Type 1 Diabetes Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Type 1 Diabetes Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Type 1 Diabetes Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Type 1 Diabetes Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Type 1 Diabetes Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Type 1 Diabetes Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Type 1 Diabetes Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Type 1 Diabetes Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Type 1 Diabetes Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Type 1 Diabetes Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Type 1 Diabetes Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Insulins
  • Others
Applications
  • Drugstore
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lily
  • AstraZeneca
  • Diamyd Therapeutics AB
  • Boehringer Ingelheim
  • Biodel
  • BHV Pharma
  • Astellas Pharma
  • Adocia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Type 1 Diabetes Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Type 1 Diabetes Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Type 1 Diabetes Drugs Market by Type
  6. 1.3.1 Insulins
  7. 1.3.2 Others
  8. 1.4 Global Type 1 Diabetes Drugs Market Size by Type
  9. 1.4.1 Global Type 1 Diabetes Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Type 1 Diabetes Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Type 1 Diabetes Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Type 1 Diabetes Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Type 1 Diabetes Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Type 1 Diabetes Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Type 1 Diabetes Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Type 1 Diabetes Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Type 1 Diabetes Drugs Industry Trends
  2. 2.2 Type 1 Diabetes Drugs Industry Drivers
  3. 2.3 Type 1 Diabetes Drugs Industry Opportunities and Challenges
  4. 2.4 Type 1 Diabetes Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Type 1 Diabetes Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Type 1 Diabetes Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Type 1 Diabetes Drugs Price (2021-2026)
  4. 3.4 Global Type 1 Diabetes Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Type 1 Diabetes Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Type 1 Diabetes Drugs Company, Product Type & Application
  7. 3.7 Global Type 1 Diabetes Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Type 1 Diabetes Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Type 1 Diabetes Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Type 1 Diabetes Drugs Tier 1, Tier 2, and Tier 3
4 Type 1 Diabetes Drugs Regional Status and Outlook
  1. 4.1 Global Type 1 Diabetes Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Type 1 Diabetes Drugs Historic Market Size by Region
  3. 4.2.1 Global Type 1 Diabetes Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Type 1 Diabetes Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Type 1 Diabetes Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Type 1 Diabetes Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Type 1 Diabetes Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Type 1 Diabetes Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Type 1 Diabetes Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Type 1 Diabetes Drugs by Application
  1. 5.1 Type 1 Diabetes Drugs Market by Application
  2. 5.1.1 Drugstore
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Type 1 Diabetes Drugs Market Size by Application
  6. 5.2.1 Global Type 1 Diabetes Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Type 1 Diabetes Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Type 1 Diabetes Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Type 1 Diabetes Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Type 1 Diabetes Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Type 1 Diabetes Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Type 1 Diabetes Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Type 1 Diabetes Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Type 1 Diabetes Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Type 1 Diabetes Drugs Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lily
  14. 6.3.1 Eli Lily Company Information
  15. 6.3.2 Eli Lily Business Overview
  16. 6.3.3 Eli Lily Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lily Type 1 Diabetes Drugs Product Portfolio
  18. 6.3.5 Eli Lily Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Type 1 Diabetes Drugs Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Diamyd Therapeutics AB
  26. 6.5.1 Diamyd Therapeutics AB Company Information
  27. 6.5.2 Diamyd Therapeutics AB Business Overview
  28. 6.5.3 Diamyd Therapeutics AB Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Diamyd Therapeutics AB Type 1 Diabetes Drugs Product Portfolio
  30. 6.5.5 Diamyd Therapeutics AB Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Type 1 Diabetes Drugs Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
  37. 6.7 Biodel
  38. 6.7.1 Biodel Company Information
  39. 6.7.2 Biodel Business Overview
  40. 6.7.3 Biodel Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biodel Type 1 Diabetes Drugs Product Portfolio
  42. 6.7.5 Biodel Recent Developments
  43. 6.8 BHV Pharma
  44. 6.8.1 BHV Pharma Company Information
  45. 6.8.2 BHV Pharma Business Overview
  46. 6.8.3 BHV Pharma Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BHV Pharma Type 1 Diabetes Drugs Product Portfolio
  48. 6.8.5 BHV Pharma Recent Developments
  49. 6.9 Astellas Pharma
  50. 6.9.1 Astellas Pharma Company Information
  51. 6.9.2 Astellas Pharma Business Overview
  52. 6.9.3 Astellas Pharma Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Astellas Pharma Type 1 Diabetes Drugs Product Portfolio
  54. 6.9.5 Astellas Pharma Recent Developments
  55. 6.10 Adocia
  56. 6.10.1 Adocia Company Information
  57. 6.10.2 Adocia Business Overview
  58. 6.10.3 Adocia Type 1 Diabetes Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Adocia Type 1 Diabetes Drugs Product Portfolio
  60. 6.10.5 Adocia Recent Developments
7 North America by Country
  1. 7.1 North America Type 1 Diabetes Drugs Sales by Country
  2. 7.1.1 North America Type 1 Diabetes Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Type 1 Diabetes Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Type 1 Diabetes Drugs Market Size by Country
  6. 7.2.1 North America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Type 1 Diabetes Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Type 1 Diabetes Drugs Sales by Country
  2. 8.1.1 Europe Type 1 Diabetes Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Type 1 Diabetes Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Type 1 Diabetes Drugs Market Size by Country
  6. 8.2.1 Europe Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Type 1 Diabetes Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Type 1 Diabetes Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Type 1 Diabetes Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Type 1 Diabetes Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Type 1 Diabetes Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Type 1 Diabetes Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Type 1 Diabetes Drugs Sales by Country
  2. 10.1.1 South America Type 1 Diabetes Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Type 1 Diabetes Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Type 1 Diabetes Drugs Market Size by Country
  6. 10.2.1 South America Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Type 1 Diabetes Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Type 1 Diabetes Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Type 1 Diabetes Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Type 1 Diabetes Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Type 1 Diabetes Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Type 1 Diabetes Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Type 1 Diabetes Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Type 1 Diabetes Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Type 1 Diabetes Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Type 1 Diabetes Drugs Value Chain Analysis
  2. 12.1.1 Type 1 Diabetes Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Type 1 Diabetes Drugs Production Mode & Process
  7. 12.2 Type 1 Diabetes Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Type 1 Diabetes Drugs Distributors
  10. 12.2.3 Type 1 Diabetes Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst